nVentic insights

Insights

All of our insights below are available free and without registration. Click on the titles for each, along with downloadable pdf files of the white papers.

Covid-19

Survival of the fittest
In the short-term, organisations must prioritise cash, champion transparency, match supply to demand as closely as possible and prioritise ruthlessly.
Back to normal
Now is the time to plan for a return of normality, whatever that might look like. Organisations need to leverage predictive analytics and stay agile, while preparing for a range of scenarios.
The new normal
Don't be fooled by wish-fulfilling prophecies, but do prepare yourself for whatever the future brings.
Big pharma inventories in a time of coronavirus
Big pharma companies normally carry substantial inventories. But will this be a good approach to dealing with the extraordinary strains put on supply chains in 2020 by the global coronavirus pandemic?

Case studies

Optimizing inventory in a context of supply disruption
True optimization is not just a name for inventory reduction. nVentic helped a manufacturing client reduce inventories while improving service levels, even in a context of significant supply disruption and other externalities.
Strategic supply chain redesign
Strategic decisions such as the overall design of a supply chain are complex and challenging to quantify well. nVentic helped a large industrial client reconfigure its footprint of production and distribution sites.
De-risking a key component supply chain
nVentic helped a manufacturing company deal with a major external risk in its supply chain.
The afterlife of a make vs buy decision
Major make vs buy decisions are often complex and strategic. Sometimes external market conditions make one reconsider the very basis of the decision. nVentic helped a global client find its way through the complexity to a balanced decision.
Industrial manufacturing inventory optimization
nVentic helped a manufacturer reduce inventories in scope by 50% while improving service levels.
Finding an extra 15% for an automotive manufacturer
A leading manufacturer thought they had already optimized inventory, but nVentic helped them find further potential for improvement.
Fixing shortages and excesses at the same time
nVentic allowed a manufacturer to pinpoint and resolve problems with both shortages and excess stocks in just a few months.

White papers

Getting your inventories in shape - a guide for CFO's
Optimizing inventory can unlock tremendous value. Here we provide a brief overview for Finance professionals, covering the benefits of inventory optimization as well as the key issues.
Bridging the gap between theory and practice in inventory management
Great work has been done in inventory optimization in the academic world, but how much is really used in practice? Here we set out our point of view, as well as explaining what nVentic is doing to bridge the gap.
The inventory challenge for the pharmaceutical industry
Pharmaceutical supply chains are long, complex and sometimes fragile, but there seems to be a major opportunity to deliver benefits through inventory optimization. Here we explore some of the issues and suggest how best to proceed.
The environmental case for inventory optimization
Excessive inventories are not just bad for your bottom line and balance sheet, they also represent unnecessary waste. We discuss how improving your inventory management can reduce your organisation's environmental impact.
The limitation of crystal balls in inventory management
It is easy to fall into the trap of thinking that a good forecast is all you need to optimize inventories. Here we show the limitations of relying on forecasts and the importance of other factors.
The constantly unrealised potential
The opportunity presented by inventory optimization is very significant, but most organisations have under-exploited it. We explore 7 of the main reasons why this is the case and what needs to be done to overcome them.
nVentic Big Pharma inventory benchmarking report 2019
The pharmaceutical industry has a major opportunity to improve its inventory management and free up significant amounts of working capital. We benchmark 30 of the biggest pharmaceutical companies in the world on their inventory performance and consider some of the visible trends.
The strategic management of inventory
Holding cost may not seem like a strategic lever, but it is a key tool that can be used to improve working capital. But how much is inventory holding cost? In this white paper we explore how to calculate it and how to use it to best effect.
The ultimate guide to reducing excess and obsolete inventory
No one likes excess and obsolete (E&O) inventory, but it is difficult to eliminate. Here we present a guide to the top 10 steps organisations can take to reduce E&O to a minimum.

Would you like to talk to one of our experts? Contact us

© 2020 nVentic GmbH